Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vaccinex Inc
(NQ:
VCNX
)
7.690
+0.590 (+8.31%)
Streaming Delayed Price
Updated: 3:57 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
70,802
Open
7.180
Bid (Size)
7.510 (1)
Ask (Size)
8.200 (7)
Prev. Close
7.100
Today's Range
6.608 - 7.690
52wk Range
4.432 - 64.89
Shares Outstanding
65,941,086
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease at the Alzheimer’s Association International Conference, Philadelphia, July 31, 2024
July 17, 2024
Pepinemab is believed to block astrocyte reactivity, a key pathology driving Alzheimer’s progression
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease
June 06, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
Performance
YTD
-27.13%
-27.13%
1 Month
+26.07%
+26.07%
3 Month
+55.67%
+55.67%
6 Month
-1.74%
-1.74%
1 Year
-87.35%
-87.35%
More News
Read More
12 Health Care Stocks Moving In Friday's Intraday Session
May 31, 2024
Via
Benzinga
VCNX Stock Earnings: Vaccinex Reported Results for Q1 2024
May 16, 2024
Via
InvestorPlace
VCNX Stock Earnings: Vaccinex Reported Results for Q4 2023
April 02, 2024
Via
InvestorPlace
Why Vaccinex (VCNX) Stock Is Trading Lower
February 15, 2024
Via
Benzinga
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 27, 2024
Via
Benzinga
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 15, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
Why Vaccinex (VCNX) Stock Is Popping Off
February 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 25, 2024
Via
Benzinga
Vaccinex Reports 2023 Financial Results and Provides Corporate Update
April 02, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
March 27, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology
February 21, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex, Inc. Announces Reverse Stock Split
February 15, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 09, 2024
Via
Benzinga
Vaccinex Announces Pricing of $3.7 Million PIPE Financing
February 07, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule
December 04, 2023
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 13, 2023
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex Reports Positive Effect of Pepinemab Treatment on New Biomarker of Brain Inflammation in Neurodegenerative Diseases
October 26, 2023
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex Reports Clinical Benefit in Interim Analyses from two Phase 2 Studies of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting
October 31, 2023
From
Vaccinex, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.